Where does Cardiac Pacemakers, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cardiac Pacemakers, Inc. ranks #369 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cardiac Pacemakers, Inc. hold?

Cardiac Pacemakers, Inc. holds 1,178 US utility patents granted between 2015 and 2025, spanning 81 technology areas.

What is Cardiac Pacemakers, Inc.'s Innovation Score?

Cardiac Pacemakers, Inc. has an Innovation Score of 64.0 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cardiac Pacemakers, Inc. focus on?

Cardiac Pacemakers, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 1,037 patents, ranking #3 of 1,943 assignees active in that subclass. Grants appear in 81 CPC subclasses total.

Is Cardiac Pacemakers, Inc.'s patent grant rate increasing or decreasing?

Cardiac Pacemakers, Inc.'s recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cardiac Pacemakers, Inc.'s patents?

Cardiac Pacemakers, Inc.'s patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cardiac Pacemakers, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cardiac Pacemakers, Inc.

USPTO PatentsView assignee record - 1,178 granted patents across 81 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cardiac ranks #369 of 49,997 tracked US assignees by granted-patent volume, with 1,178 patents across 81 technology areas.

#369
of 49,997 US assignees by volume: Top 2%
by Innovation Score (64.0/100): 17.9
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R369 · US Corporation #369 · 1,178 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-LARGE 1.2K grants
TOP-DECILE #369/49,997
PHOTO-FINISH Karsten Manufacturing
CPC-WIDE A61N · 81 areas
INNOV-STRONG 64.0/100
CLAIMS-RICH 17.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Karsten Manufacturing Corporation (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cardiac’s 64.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 24.4 pts (38%) Velocity 3.8 pts (6%) Breadth 25.0 pts (39%) Claim depth 10.7 pts (17%)

Qualcomm Incorporated · highest

85
Crown Equipment · near

64
Cardiac Pacemakers · this assignee

64
Dana Motion Systems… · near

64
Comadur · near

64
Royal Bank of Canada · near

64
3D Lighting… · lowest

7

What this shows Cardiac's Innovation Score is 64.0/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cardiac?

Each dot is one of Cardiac’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardiac’s own 17.9 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cardiac vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Cardiac's grant cadence moved

Between 2020–2024, Cardiac Pacemakers, Inc. received 434 grants versus 721 in 2015–2019 (-40% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 193 grants and bottomed in 2024 at 42. Lead class A61N accounts for 88% of the portfolio across 81 subclasses. Volume neighbours: Cummins Inc. (#365) and Quanta Computer Inc. (#373).

Cardiac's three-year grant acceleration

From 2019–2021 to 2022–2024, Cardiac Pacemakers, Inc. moved from 356 to 204 grants (0.57x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,516. See the growth leaderboard.

Cummins

1,191
HRL Laboratories

1,188
UOP

1,188
Vestas Wind Syste…

1,179
Cardiac Pacemakers ◀

1,178
Karsten Manufactu…

1,177
Kla-tencor

1,173
Smith & Nephew

1,172
Quanta Computer

1,171

What this shows Cardiac holds 1,178 patents at rank #369, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cardiac

By rank, the assignees closest to #369 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cardiac's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardiac, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Cardiac ranks #3 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (64 here).

Dana Motion Systems Italia S.R.L. 64 Royal Bank of Canada 64 Comadur SA 64 Crown Equipment Corporation 64

Similar claim depth

Nearest assignees by average claims per patent (17.9 here).

Shimano Inc. 17.9 avg Saint-gobain Performance Plastics Corporation 17.9 avg Ericsson AB 17.9 avg Microvision, Inc. 17.9 avg

Cardiac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cardiac Pacemakers, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	193	16.4%
2016	159	13.5%
2017	153	13.0%
2018	90	7.6%
2019	126	10.7%
2020	121	10.3%
2021	109	9.3%
2022	99	8.4%
2023	63	5.3%
2024	42	3.6%
2025partial year	23	2.0%

Which technologies does Cardiac Pacemakers, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1,037

A61B - DIAGNOSIS; SURGERY; Identification 609

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 165

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 73

Y10T - Technical Subjects Covered BY Former US Classification 67

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 37

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 37

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 26

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 23

H01G - CAPACITORS; Capacitors, Rectifiers, Detectors, Switching Devices, Light-sensitive OR Temperature-sensitive Devices OF THE Electrolytic Type 22

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 21

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 19

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 17

H04B - Transmission 16

H01Q - Antennas, i.e. Radio Aerials 15

Top 15 of 81 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cardiac Pacemakers, Inc.'s patent record in context - here's where to go next.

Cardiac Pacemakers, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 88% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #369 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cardiac Pacemakers, Inc. against Cummins Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 64.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.